NASD | Health Care | Biotechnology

Precision BioSciences Inc. (DTIL)

LAST (3 Apr)
4.71
+0.02  (+0.43%)
MARKET CAP
18.840 M
VOLUME
78,729
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 3 Apr
Open 4.51
Previous Close 4.69
Day Range 4.51 - 4.79
52-Week Range 3.61 - 15.97
All-Time High 710.11
Avg. Volume (50-day) 125,264.4
EPS (TTM) 1.89
Next Earnings Date 2025-05-13 (BMO)
Last Earnings Date 2025-03-26
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options No
Fundamentals
P/E Ratio 2.48
PEG Ratio 0.02
Price to Book 0.68
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 68.70 M
Revenue per Share (TTM) 8.59
Shares Outstanding 4.064 M
Share Float (%) 3.45 M (85.00%)
% Held by Institutions 95.38
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 4.92 (-4.27%)
+/- SMA(50) 5.09 (-7.47%)
+/- SMA(200) 7.45 (-36.78%)
5-Day Perf. +3.74%
1-Month Perf. -5.8%
3-Month Perf. -0.84%
6-Month Perf. -50.58%
YTD Perf. +23.62%
1-Year Perf. -69.49%
RSI(14) 43.75
ATR(14) 0.39
ADX(14) 16.93
Beta (5Y) 1.59
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

DTIL

25.4
(+6.2)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Precision BioSciences Inc.

-
Durham, North Carolina
http://www.precisionbioscie...
Sector: Health Care
Industry: Biotechnology
Employees: 108
Description

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Predefined Scans with DTIL View All  

DTIL has triggered the following predefined scans:

P&F Double Bottom Breakdown
Alerts for DTIL View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with DTIL

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.